Peripheral Artery Occlusive Disease (PAOD)-Pipeline Insights, 2015

1
Peripheral Artery Occlusive Disease
(PAOD)-Pipeline Insights, 2015
2
Summary
Summary Peripheral Artery Occlusive Disease
(PAOD)- Pipeline Insights, 2015, provides the
in-depth analysis of the pipeline assets across
the Peripheral Artery Occlusive Disease (PAOD).
The main objective of this report to track
competitor pipeline molecules, related research
activities, technology, collaborations,
in-licensing and out-licensing deals. The
Peripheral Artery Occlusive Disease (PAOD) Report
helps to identify emerging players with
potentially strong product information and create
effective counter-strategies to gain competitive
advantage. Peripheral Artery Occlusive Disease
(PAOD)- Pipeline Insights, 2015 Report covers the
Peripheral Artery Occlusive Disease (PAOD)
pipeline molecules at various stages of
development like Pre-registration phase, clinical
phases (Phase III, Phase II Phase I).
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
3

The Report also provides Peripheral Artery
Occlusive Disease (PAOD) related therapeutic
assessments by molecule type, route of
administration, monotherapy and combination
products. The Report also highlights the
discontinued and inactive projects in pipeline
for Peripheral Artery Occlusive Disease
(PAOD). Scope -The report provides a Peripheral
Artery Occlusive Disease (PAOD) Landscape across
the globe - The report provides drug profiles
which includes product description, MOA,
licensors collaborators, technology,
development partner and chemical information
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
4

- Coverage of the Peripheral Artery Occlusive
Disease (PAOD) pipeline on the basis of target,
MOA, route of administration, technology involved
and molecule type - The report reviews key
players involved in the therapeutics development
for Peripheral Artery Occlusive Disease (PAOD)
and also provide company profiling - Pipeline
products coverage based on various stages of
development from NDA filings to discovery. -
Provides pipeline assessment by monotherapy and
combination therapy products, stage of
development and molecule type
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
5

Reasons to buy - Complete Pipeline intelligence
and complete understanding over therapeutics
development for Peripheral Artery Occlusive
Disease (PAOD) - Identify the relationship
between the drugs and use it for target finding,
drug repurposing, and precision medicine. -
Track your competitors and develop strategic
initiatives to support your drug development
activities. - Optimize your portfolio and keep
you in touch with the rapidly changing
pharmaceutical markets, and make the best
decisions for your business.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
6
Table of Contents

• Peripheral Artery Occlusive Disease (PAOD)
  Overview
• Peripheral Artery Occlusive Disease (PAOD)
  Pipeline Therapeutics
• Peripheral Artery Occlusive Disease (PAOD)
  Therapeutics under Development by Companies
• Peripheral Artery Occlusive Disease (PAOD) Late
  Stage Products (Filed and Phase III)
• Comparative Analysis
• Peripheral Artery Occlusive Disease (PAOD) Mid
  Clinical Stage Products (Phase II)
• Comparative Analysis
• Peripheral Artery Occlusive Disease (PAOD) Early
  Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Peripheral Artery Occlusive Disease (PAOD)
  Discovery and Pre-Clinical Stage Products

W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
7
To view the full Executive Summary and Table
of Contents, please visit Peripheral Artery
Occlusive Disease (PAOD)-Pipeline Insights,
2015 Contact Us-Call India 91-22-27810772/73
Email id info_at_bharatbook.com Website
www.bharatbook.com Our Blog https//www.bharatb
ook.com/blog/

W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com